Up-regulation of protein l-isoaspartyl methyltransferase expression by lithium is mediated by glycogen synthase kinase-3 inactivation and β-catenin stabilization

Neuropharmacology

Volumn 55, Issue 5, 2008, Pages 669-676

  Lamarre, Mélanie ^a   Desrosiers, Richard R ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Catenin; Glycogen synthase kinase 3; Lithium; Protein l isoaspartyl methyltransferase; Valproic acid

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; 2 (3 CHLORO 4 HYDROXYANILINO) 3 (2 NITROPHENYL)MALEIMIDE; ANTICONVULSIVE AGENT; BETA CATENIN; DACTINOMYCIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; LITHIUM; MESSENGER RNA; METHYLTRANSFERASE; PROTEIN ISOASPARTYL METHYLTRANSFERASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VALPROIC ACID;

ARTICLE; ASTROCYTOMA CELL; CELL AGING; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INACTIVATION; EPILEPSY; HUMAN; HUMAN CELL; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRUCTURE ACTIVITY RELATION;

ADJUVANTS, IMMUNOLOGIC; ASTROCYTOMA; BETA CATENIN; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; LITHIUM CHLORIDE; PROTEIN D-ASPARTATE-L-ISOASPARTATE METHYLTRANSFERASE; RNA, MESSENGER; RNA, SMALL INTERFERING; TIME FACTORS; UP-REGULATION; VALPROIC ACID;

EID: 50849134835     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.05.033     Document Type: Article

References (46)

1. Aswad D.W., Paranandi M.V., and Schurter B.T. Isoaspartate in peptides and proteins: formation, significance, and analysis. J. Pharm. Biomed. Anal. 21 (2000) 1129-1136
2. Beaulieu J.M., Sotnikova T.D., Yao W.D., Kockeritz L., Woodgett J.R., Gainetdinov R.R., and Caron M.G. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 5099-5104
3. Beaulieu J.M., Marion S., Rodriguiz R.M., Medvedev I.O., Sotnikova T.D., Ghisi V., Wetsel W.C., Lefkowitz R.J., Gainetdinov R.R., and Caron M.G. A beta-arrestin 2 signaling complex mediates lithium action on behavior. Cell 132 (2008) 125-136
4. Berridge M.J., Downes C.P., and Hanley M.R. Neural and developmental actions of lithium: a unifying hypothesis. Cell 59 (1989) 411-419
5. Brault V., Moore R., Kutsch S., Ishibashi M., Rowitch D.H., McMahon A.P., Sommer L., Boussadia O., and Kemler R. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development 8 (2001) 1253-1264
6. Campos V.E., Du M., and Li Y. Increased seizure susceptibility and cortical malformation in β-catenin mutant mice. Biochem. Biophys. Res. Commun. 320 (2004) 606-614
7. Caron A., Desrosiers R.R., and Béliveau R. Kidney ischemia-reperfusion regulates expression and distribution of tubulin subunits, beta-actin and rho GTPases in proximal tubules. Arch. Biochem. Biophys. 1 (2004) 31-46
8. Chalecka-Franaszek E., and Chuang D.M. Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 8745-8750
9. Chen R., Ding W.V., and McCormick F. Wnt signaling to β-catenin involves two interactive components. Glycogen synthase kinase-3β inhibition and activation of protein kinase C. J. Biol. Chem. 275 (2000) 17894-17899
10. Chen S., Guttridge D.C., You Z., Zhang Z., Fribley A., Mayo M.W., Kitajewski J., and Wang C.Y. Wnt-1 signaling inhibits apoptosis by activating beta-catenin/T cell factor-mediated transcription. J. Cell. Biol. 152 (2001) 87-96
11. Cross D.A., Culbert A.A., Chalmers K.A., Facci L., Skaper S.D., and Reith A.D. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378 (1995) 785-789
12. Cross D.A., Culbert A.A., Chalmers K.A., Facci L., Skaper S.D., and Reith A.D. Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurons from death. J. Neurochem. 77 (2001) 94-102
13. Cueille N., Blanc C.T., Riederer I.M., and Riederer B.M. Microtubule-associated protein 1B binds glyceraldehyde-3-phosphate dehydrogenase. J. Proteom. Res. 6 (2007) 2640-2647
14. De Sarno P., Li X., and Jope R.S. Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. Neuropharmacology 43 (2002) 1158-1164
15. Doble B.W., and Woodgett J.R. GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell Sci. 116 (2003) 1175-1186
16. Eickholt B.J., Towers G.J., Ryves W.J., Eikel D., Adley K., Ylinen L.M., Chadborn N.H., Harwood A.J., Nau H., and Williams R.S. Effects of valproic acid derivatives on inositol trisphosphate depletion, teratogenicity, glycogen synthase kinase-3beta inhibition, and viral replication: a screening approach for new bipolar disorder drugs derived from the valproic acid core structure. Mol. Pharmacol. 67 (2005) 1426-1433
17. Frame S., and Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem. J. 359 (2001) 1-16
18. Gould T.D., and Manji H.K. The Wnt signalling pathway in bipolar disorder. Neuroscientist 8 (2002) 497-511
19. Harwood A.J., and Agam G. Search for a common mechanism of mood stabilizers. Biochem. Pharmacol. 66 (2003) 179-189
20. Hetman M., Cavanaugh J.E., Kimelman D., and Xia Z. Role of Glycogen synthase kinase-3b in neuronal apoptosis induced by trophic withdrawal. J. Neurosci. 7 (2000) 2567-2574
21. Huebscher K.J., Lee J., Rovelli G., Ludin B., Matus A., Stauffer D., and Fürst P. Protein isoaspartyl methyltransferase protects from Bax-induced apoptosis. Gene 240 (1999) 333-341
22. Jope R.S. Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol. Sci. 24 (2003) 441-443
23. Kikuchi A., Kishida S., and Yamamoto H. Regulation of Wnt signaling by protein-protein interaction and post-translational modifications. Exp. Mol. Med. 38 (2006) 1-10
24. Kim E., Lowenson J.D., MacLaren D.C., Clarke S., and Young S.G. Deficiency of a protein-repair enzyme results in the accumulation of altered proteins, retardation of growth, and fatal seizures in mice. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 6132-6137
25. Klein P.S., and Melton D.A. A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 8455-8459
26. Kondo T., Shirasawa T., Itoyama Y., and Mori H. Embryonic genes expressed in Alzheimer's disease brains. Neurosci. Lett. 209 (1996) 157-160
27. Kostrouchova M., Kostrouch Z., and Kostrouchova M. Valproic acid, a molecular lead to multiple regulatory pathways. Folia Biol. (Praha) 53 (2007) 37-49
28. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
29. Lanthier J., and Desrosiers R.R. Protein l-isoaspartyl methyltransferase repairs abnormal aspartyl residues accumulated in vivo in type-I collagen and restores cell migration. Exp. Cell Res. 293 (2004) 96-105
30. Lanthier J., and Desrosiers R.R. Regulation of protein L-isoaspartyl methyltransferase by cell-matrix interactions: involvement of integrin alphavbeta3, PI 3-kinase, and the proteasome. Biochem. Cell Biol. 84 (2006) 684-894
31. Lanthier J., Bouthillier A., Lapointe M., Demeule M., Béliveau R., and Desrosiers R.R. Down-regulation of protein l-isoaspartyl methyltransferase in human epileptic hippocampus contributes to generation of damaged tubulin. J. Neurochem. 83 (2002) 581-591
32. Lapointe M., Lanthier J., Moumdjian R., Régina A., and Desrosiers R.R. Expression and activity of l-isoaspartyl methyltransferase decrease in stage progression of human astrocytic tumors. Brain Res. Mol. Brain Res. 135 (2005) 93-103
33. Lee S.M., Tole S., Grove E., and McMahon A.P. A local Wnt-3a signal is required for development of the mammalian hippocampus. Development 127 (2000) 457-467
34. Linseman D.A., Butts B.D., Precht T.A., Phelps R.A., Le S.S., Laessig T.A., Bouchard R.J., Florez-McClure M.L., and Heidenreich K.A. Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis. J. Neurosci. 44 (2004) 9993-10002
35. Mattson M.P. Apoptosis in neurodegenerative disorders. Nat. Rev. Mol. Cell. Biol. 1 (2000) 120-129
36. Pan T., Li X., Xie W., Jankovic J., and Le W. Valproic acid-mediated Hsp70 induction and anti-apoptotic neuroprotection in SH-SY5Y cells. FEBS Lett. 579 (2005) 6716-6720
37. Phiel C.J., Zhang F., Huang E.Y., Guenther M.G., Lazar M.A., and Klein P.S. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 276 (2001) 36734-36741
38. Ryves W.J., and Harwood A.J. Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem. Biophys. Res. Commun. 280 (2001) 720-725
39. Shimuzu T., Matsuoka Y., and Shirasawa T. Biological significance of isoaspartate and its repair system. Biol. Pharm. Bull. 28 (2004) 1590-1596
40. Sinha D., Wang Z., Ruchalski K.L., Levine J.S., Krishnan S., Lieberthal W., Schwartz J.H., and Borkan S.C. Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors. Am. J. Physiol. Renal Physiol. 288 (2005) F703-F713
41. Spittaels K., Van den Haute C., Van Dorpe J., Terwel D., Vandezande K., Lasrado R., Bruynseels K., Irizarry M., Verhoye M., Van Lint J., Vandenheede J.R., Ashton D., Mercken M., Loos R., Hyman B., Van der Linden A., Geerts H., and Van Leuven F. Neonatal neuronal overexpression of glycogen synthase kinase-3 beta reduces brain size in transgenic mice. Neuroscience 4 (2002) 797-808
42. Stambolic V., Ruel L., and Woodgett J.R. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr. Biol. 12 (1996) 1664-1668
43. Sutula T., Cascino G., Cavazos J., Parada I., and Ramirez L. Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann. Neurol. 26 (1989) 321-330
44. Williams R.S.B., and Harwood A.J. Lithium therapy and signal transduction. Trends Pharmacol. Sci. 21 (2000) 61-64
45. Yamamoto A., Takagi H., and Kitamura D. Deficiency in protein l-isoaspartyl methyltransferase results in a fatal progressive epilepsy. J. Neurosci. 18 (1998) 2063-2074
46. Zhang F., Phiel C.J., Spece L., Gurvich N., and Klein P.S. Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3. J. Biol. Chem. 278 (2003) 33067-33077